The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Expansion and Differentiation of Human Embryonic Stem Cells to Endoderm Progeny in a Microcarrier Stirred-Suspension Culture
Open accessAbstract
Embryonic stem cells (ESCs) with their abilities for extensive proliferation and multi-lineage differentiation can serve as a renewable source of cellular material in regenerative medicine. However, the development of processes for large-scale generation of human ESCs (hESCs) or their progeny will be necessary before hESC-based therapies become a reality. We hypothesized that microcarrier stirred-suspension bioreactors characterized by scalability, straightforward operation, and tight control of the culture environment can be used for hESC culture and directed differentiation. Under appropriate conditions, the concentration of hESCs cultured in a microcarrier bioreactor increased 34- to 45-fold over 8 days. The cells retained the expression of pluripotency markers such as OCT3/4A, NANOG, and SSEA4, as assessed by quantitative PCR, immunocytochemistry, and flow cytometry. We further hypothesized that hESCs on microcarriers can be induced to definitive endoderm (DE) when incubated with physiologically relevant factors. In contrast to embryoid body cultures, all hESCs on microcarriers are exposed to soluble stimuli in the bulk medium facilitating efficient transition to DE. After reaching a peak concentration, hESCs in microcarrier cultures were incubated in medium containing activin A, Wnt3a, and low concentration of serum. More than 80% of differentiated hESCs coexpressed FOXA2 and SOX17 in addition to other DE markers, whereas the expression of non-DE genes was either absent or minimal. We also demonstrate that the hESC-to-DE induction in microcarrier cultures is scalable. Our findings support the use of microcarrier bioreactors for the generation of endoderm progeny from hESCs including pancreatic islets and liver cells in therapeutically useful quantities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Kroon, E., Martinson, L. A., Kadoya, K., Bang, A. G., Kelly, O. G., Eliazer, S., Young, H., Richardson, M., Smart, N. G., Cunningham, J., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1393 · Cited by 1,843 · cited 1×
“Differentiation of hESCs cultured on microcarriers was initiated by exchanging the CM with differentiation medium known to induce DE formation in dishes.(4,8) Although there is no single DE-specific marker or functional assay that can unequivocally identify this cell type, several lines of evidence indicate that a maj…”
MethodFive-Year Follow-Up After Clinical Islet Transplantation
Ryan, E. A., Paty, B. W., Senior, P. A., Bigam, D., Alfadhli, E., Kneteman, N. M., Lakey, J. R. T., & Shapiro, A. M. J. (2005) · Diabetes · doi:10.2337/diabetes.54.7.2060 · Cited by 1,641
Depletion of definitive gut endoderm in Sox17 -null mutant mice
Kanai-Azuma, M., Kanai, Y., Gad, J. M., Tajima, Y., Taya, C., Kurohmaru, M., Sanai, Y., Yonekawa, H., Yazaki, K., Tam, P. P. L., et al. (2002) · Development · doi:10.1242/dev.129.10.2367 · Cited by 704
Ang, S.-L., Wierda, A., Wong, D., Stevens, K. A., Cascio, S., Rossant, J., & Zaret, K. S. (1993) · Development · doi:10.1242/dev.119.4.1301 · Cited by 618
Induction and monitoring of definitive and visceral endoderm differentiation of mouse ES cells
Yasunaga, M., Tada, S., Torikai-Nishikawa, S., Nakano, Y., Okada, M., Jakt, L. M., Nishikawa, S., Chiba, T., Era, T., & Nishikawa, S.-I. (2005) · Nature Biotechnology · doi:10.1038/nbt1167 · Cited by 471
Cited by
Schulz, T. C., Young, H. Y., Agulnick, A. D., Babin, M. J., Baetge, E. E., Bang, A. G., Bhoumik, A., Cepa, I., Cesario, R. M., Haakmeester, C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037004 · Cited by 428
Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics
Chen, K. G., Mallon, B. S., McKay, R. D. G., & Robey, P. G. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2013.12.005 · Cited by 358
“This method yielded a 34- to 45-fold increase in hESC numbers in 8 days (FIPD = 4.3 to 5.6), with a definitive endoderm Cell Stem Cell 14, January 2, 2014 ª2014 Elsevier Inc. 21 efficiency greater than 80% as determined by coexpression of SOX17 and FOXA2 (Lock and Tzanakakis, 2009).”
BackgroundMethodInfluentialAdvances and challenges in stem cell culture
McKee, C., & Chaudhry, G. R. (2017) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2017.07.051 · Cited by 323
Process engineering of human pluripotent stem cells for clinical application
Serra, M., Brito, C., Correia, C., & Alves, P. M. (2012) · Trends in Biotechnology · doi:10.1016/j.tibtech.2012.03.003 · Cited by 303
Chen, A. K.-L., Reuveny, S., & Oh, S. K. W. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.03.006 · Cited by 292
Microcarriers for Upscaling Cultured Meat Production
Bodiou, V., Moutsatsou, P., & Post, M. J. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.00010 · Cited by 272
Scalable Stirred-Suspension Bioreactor Culture of Human Pluripotent Stem Cells
Kehoe, D. E., Jing, D., Lock, L. T., & Tzanakakis, E. S. (2010) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0454 · Cited by 264
Self-citationEmerging routes to the generation of functional β-cells for diabetes mellitus cell therapy
Nair, G. G., Tzanakakis, E. S., & Hebrok, M. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0375-3 · Cited by 134
Self-citationBardy, J., Chen, A. K., Lim, Y. M., Wu, S., Wei, S., Weiping, H., Chan, K., Reuveny, S., & Oh, S. K. W. (2013) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2012.0146 · Cited by 111
Flow Characterization of a Spinner Flask for Induced Pluripotent Stem Cell Culture Application
Ismadi, M.-Z., Gupta, P., Fouras, A., Verma, P., Jadhav, S., Bellare, J., & Hourigan, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106493 · Cited by 93
“Furthermore, the cell yield can be further enhanced by the introduction of microcarriers, which increase the surface area for cell growth as shown in previous studies [19,20,21,22,23,24].”
ResultEnd-to-End Platform for Human Pluripotent Stem Cell Manufacturing
Pandey, P. R., Tomney, A., Woon, M. T., Uth, N., Shafighi, F., Ngabo, I., Vallabhaneni, H., Levinson, Y., Abraham, E., & Friedrich Ben-Nun, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010089 · Cited by 42
Lam, A. T.-L., Chen, A. K.-L., Ting, S. Q.-P., Reuveny, S., & Oh, S. K.-W. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.09.079 · Cited by 36
“A few groups have reported on the development of such systems [16,18,19,36].”
BackgroundMethod
Metadata
- Authors
- Lock, L. T., & Tzanakakis, E. S.
- Venue
- Tissue Engineering Part A
- Publisher
- SAGE Publications
- Published
- 2009-08
- Volume
- 15
- Issue
- 8
- Pages
- 2051-2063
- ISSN
- 1937-3341 (ISSN-L)
- 1937-335X
- OpenAlex
- W2048973711
- Cited by
- 183
- References
- 6
- FWCI
- 8.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.